Contact UsSiteMap
Home Puzzle game Online tutoring Life information Financial community Real Estate Agents More

Fashion

Scintimun® Commercialization Partnership with Curium Pharma

MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph

01-14

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.

01-14

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on

01-14

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody

01-13

MLVision M5 Unveiled at CES 2025: Pioneering Innovation in Wearable Technology with the World's Lightest AI-Powered AR Glasses

LAS VEGAS,Jan. 11,2025-- AtCES 2025,MLVision has officially launched its groundbreaking MLVision M5,setting a new global standard for wearable technology. Weighing a mere 25.8 grams,the MLVision M5 is

01-13

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licens

01-13

Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio

HANGZHOU,China,Jan. 10,2025--HangzhouSciwind Biosciences Co.,a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases,today announced a licens

01-11

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a

01-11

NAVEE Launches ST3 Pro and GT3 Pro at CES 2025, Receives UL and TÜV Rheinland Certifications

LAS VEGAS,Jan. 10,2025-- NAVEE,a global leader in intelligent short-distance mobility,today announced the North American launch of its flagship electric scooters,ST3 Pro and GT3 Pro,at CES 2025. The e

01-11

XbotPark Showcases Over 30 Incubated Hardware Startups at CES 2025

LAS VEGAS,Jan. 9,2025-- XbotPark,a leading startup incubator specializing in robotics and smart hardware,debuted over 30 incubated startups and its supply chain platform at CES 2025. This milestone de

01-10

Home Previous 19 20 21 22 23 24 25 Next Tail

10 Items Per Page (Page 22 / 68) Total 675 Items

Disclaimer

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright2009-2020 Canadian Finance Weekly    Contact Us SiteMap